Please let us know if you have feedbackDive Brief:The CMS is ending a Biden-era program that brought down premiums for Medicare Part D prescription drug plans. The agency announced Tuesday it planned to wrap up the Part D Premium Stabilization Demonstration after this year. In a bid to keep premiums and enrollment in Medicare steady, the CMS launched the Part D Premium Stabilization Demonstration. The CMS also released the average national monthly bid submitted by insurers for 2027 prescription drug plans on Tuesday — $296.05, a 24% increase from last year. Drug spending, especially for expensive conditions like cancer and pricey GLP-1s, are a significant driver of growing spending, CMS actuaries say.